title: Manipulations of the renin-angiotensin system and intake of a sweetened alcoholic beverage among rats.
abstract: Standard laboratory rats were maintained on a daily regimen involving deprivation of fluids for 22 h followed by a 2-h opportunity to drink water and a sweetened alcoholic beverage. Angiotensin II, in doses ranging from 0.1 to 1.25 mg/kg, dose relatedly decreased rats' mean intake of ethanol. All doses increased rats' mean intake of water. Angiotensin II, 0.25 mg/kg, reliably reduced intake of ethanol when it was presented alone during the 1st h of the daily 2-h drinking session, and reliably increased intake of water when it was subsequently presented alone during the 2nd h. Thus the reduction in intake of ethanol seen when the alcoholic beverage is presented concurrently with water is probably not merely due to the increase in intake of water. Lisinopril, an angiotensin converting enzyme inhibitor, in doses of 0.3, 1.0, and 3.0 mg/kg, dose relatedly decreased intake of ethanol, but only after several days of injections. Concurrent intake of water was increased dose relatedly. When injections of lisinopril ceased, intakes of both ethanol and water took several days to return to control levels. Pretreatment with lisinopril, 3.0 mg/kg, for 8 days, had no effect on subsequent intakes of either water or ethanol. Lisinopril, 3.0 mg/kg, had no effect on rats' intake of a sweet solution without ethanol. These results confirm previous work and extend the data base supporting the idea that the renin-angiotensin system plays a role in modulating intake of ethanol.
authors.affiliation: Department of Psychology, Rensselaer Polytechnic Institute, Troy, NY 12180-3590.
authors.forename: C L
authors.initials: CL
authors.lastname: Hubbell
authors.forename: G A
authors.initials: GA
authors.lastname: Chrisbacher
authors.forename: E J
authors.initials: EJ
authors.lastname: Bilsky
authors.forename: L D
authors.initials: LD
authors.lastname: Reid
mesh_terms: D000428:Alcohol Drinking; D000434:Alcoholic Beverages; D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004326:Drinking / Q000187:drug effects; D004656:Enalapril / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D000431:Ethanol / Q000008:administration & dosage*; D017706:Lisinopril; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology*; D013395:Sucrose / Q000008:administration & dosage; D014868:Water Deprivation
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D000431:Ethanol; D013395:Sucrose; D004656:Enalapril; D017706:Lisinopril